Skip to main content

What the FDA labels say about taking them together

Fluvastatin and mifepristone

Mifepristone's FDA label of September 25, 2025 names fluvastatin in its drug interactions section; the fluvastatin labels PlainMeds reads (2) do not name mifepristone. The mifepristone label: “Mifepristone significantly increased exposure of fluvastatin, a typical CYP2C8/2C9 substrate, in healthy subjects.”

Check it at the source: the fluvastatin FDA label on DailyMed (effective April 21, 2025, Teva Pharmaceuticals USA, Inc.); the mifepristone FDA label on DailyMed (effective September 25, 2025, Corcept Therapeutics Incorporated).

What does the fluvastatin label say about mifepristone?

Fluvastatin's label (effective April 21, 2025) and its 1 other brand-application label do not name mifepristone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Fluvastatin), Teva Pharmaceuticals USA, Inc., effective April 21, 2025 (SPL set aad8b373-0aec-4efb-8e61-3d8114b31127), via openFDA; the full label on DailyMed

What does the mifepristone label say about fluvastatin?

Mifepristone label, drug interactions

Mifepristone significantly increased exposure of fluvastatin, a typical CYP2C8/2C9 substrate, in healthy subjects.

Source: FDA drug label (Mifepristone), Corcept Therapeutics Incorporated, effective September 25, 2025 (SPL set 63c068cd-9370-460f-829b-70e8c7ebe91e), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

4Fluvastatin generic labelers
3Mifepristone generic labelers
FluvastatinMifepristone
Labeled forHigh cholesteroln/a
Boxed warningNoYes
Pharmacy cost (NADAC)$2.88 per tablet 80 mg tabletn/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?